Last Updated: November 8, 2026

List of Excipients in API ticagrelor

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ticagrelor

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 FERRIC OXIDE YELLOW
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 HYDROXYPROPYL CELLULOSE
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 HYPROMELLOSE
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 MAGNESIUM STEARATE
AstraZeneca Pharmaceuticals LP BRILINTA ticagrelor 0186-0777 MANNITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing ticagrelor

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 FERROSOFERRIC OXIDE
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 HYPROMELLOSE 2910
Mylan Pharmaceuticals Inc ticagrelor 0378-2214 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for ticagrelor

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CALCIUM CARBONATE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOMALT

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POWDERED CELLULOSE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links